10x Genomics (TXG) falls 0.78% in Active Trading on January 14

Equities Staff  |

10x Genomics Inc - Class A (NASDAQ: TXG), a Pleasanton, California, company, fell to close at $104.00 Friday after losing $0.82 (0.78%) on volume of 2,044,219 shares. The stock ranged from a high of $106.81 to a low of $98.74 while 10x Genomics’s market cap now stands at $9,524,943,168.

About 10x Genomics Inc - Class A

10x Genomics is an American biotechnology company that designs and manufactures gene sequencing technology used in scientific research. It was founded in 2012 by Serge Saxonov, Ben Hindson, and Kevin Ness.

Visit 10x Genomics Inc - Class A’s profile for more information.

About The Nasdaq Stock Market

The Nasdaq Stock Market is a global leader in trading data and services, and equities and options listing. Nasdaq is the world's leading exchange for options volume and is home to the five largest US companies - Apple, Microsoft, Amazon, Alphabet and Facebook.

To get more information on 10x Genomics Inc - Class A and to follow the company’s latest updates, you can visit the company’s profile page here: 10x Genomics Inc - Class A’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Trending Articles

Commodities Post Strongest Gains in Over a Decade
Charlie Munger Doubles Down on Alibaba While the Fed Signals Tightening
Commodities — Assessing 2021 and Forecasting 2022

Market Movers

Sponsored Financial Content